Collaboration Aims to Develop First Intranasal Therapy for Mild Traumatic Brain Injury Aka Concussion, Establishing a Comprehensive Test-to-Treat Platform SARASOTA, Fla. and RICHMOND, Va., Feb. 11, ...
BUFFALO, N.Y. – Adults with concussion or mild traumatic brain injury (TBI) who are seen in the primary care setting or discharged from the emergency department are often told to wait to see if their ...
Oragenics submitted its Investigator's Brochure for ONP-002, preparing for a Phase II trial for mild traumatic brain injury. Oragenics, Inc., a biotechnology company based in Sarasota, Florida, ...
Outlines clinical and growth catalysts for ONP-002 in concussion and mild traumatic brain injury (mTBI) Fully prepared to initiate near-term ...
Almost half of people who suffer a concussion still show symptoms of brain injury six months later, reveals new research. Even mild concussions can cause long-lasting effects to the brain, say ...
The Centers for Disease Control and Prevention has issued guidelines for the first time on treating children with concussions, saying they will provide doctors with the "tools they need to ensure the ...
The team at University Orthopedics offers accessible, effective, and important concussion treatments
Concussions are a Mild Traumatic Brain Injury (mTBI) that need to be taken seriously. As our overall understanding of concussions and recovery from these brain injuries improves, Physical Therapy has ...
SAN DIEGO--(BUSINESS WIRE)--Two studies by scientists at Hospital for Special Surgery (HSS) offer possible insights into treating mild traumatic brain injury (mTBI), including a potential blood ...
Hello Psychology Today readers. I'm excited to be blogging here. I was like you once -- living a full life, enjoying dinners with friends, laughing at my pets' antics, helping out and being helped by ...
Oragenics is a development-stage biotechnology company focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating ...
Sarasota, Fla., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“the “Company”) a clinical-stage biotechnology company developing brain-targeted therapeutics through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results